Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Determining Dose Equivalence Between Oral and Transdermal Estrogen Treatment in Women With Turner Syndrome - A Randomized Study

NCT06544473 is registered in ClinicalTrials.gov with Aarhus University Hospital as lead sponsor.

NCT NCT06544473
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06544473 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Determining Dose Equivalence Between Oral and Transdermal Estrogen Treatment in Women With Turner Syndrome - A Randomized Study
Lead sponsor
Aarhus University Hospital
Phase
Phase 4
Overall status
Recruiting
Start date
November 29, 2021
Completion date
December 31, 2026
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

estrogen deficiency, estrogen replacement therapy, hormone replacement therapy, hypogonadism; ovarian, turner syndrome